• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA Gomafu 通过海绵吸附 miR-139-5p 上调 Foxo1 表达促进肝脏胰岛素抵抗。

Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.

机构信息

Department of Endocrinology, Clinical Medical College of Yangzhou University, Yangzhou, China.

Department of Enphrology, Clinical Medical College of Yangzhou University, Yangzhou, China.

出版信息

Cell Death Dis. 2018 Feb 19;9(3):289. doi: 10.1038/s41419-018-0321-7.

DOI:10.1038/s41419-018-0321-7
PMID:29459686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5833404/
Abstract

Long non-coding RNA Gomafu is involved in diabetes-related diseases. However, its role in insulin resistance (IR) remains unclear. Our objective is to explore the role of Gomafu in hepatic IR and glucose intolerance. Gomafu expression was determined in livers of ob/ob mice and high-fat diet (HFD) mice. The binding activity of NF-κB on the Gomafu promoter was measured by chromatin immunoprecipitation and quantitative real-time PCR assays. Increased Gomafu expression was observed in the livers of obese mice. Besides, the binding of NF-κB on the Gomafu promoter was also observed in hepatocytes from ob/ob mice. Further study showed that knockdown of NF-κB p65 alleviated the increase in hepatic Gomafu expression in vivo and in vitro. Knockdown of hepatic Gomafu inhibited hepatic glucose production (HGP) and improved insulin sensitivity in obese mice, whereas, overexpression of hepatic Gomafu resulted in an increase in random and fasting blood glucose levels in lean mice. In addition, we demonstrated that Gomafu functioned as miR-139 sponge and led to the de-repression of its target gene Foxo1, which played an important role in gluconeogenesis and HGP in hepatocytes. Finally, silenced Foxo1 expression abolished the effect of Gomafu overexpression on gluconeogenesis and glucose production in hepatocytes. Taken together, our data suggested that the increase in Gomafu expression contributed to hepatic IR in obese mice.

摘要

长链非编码 RNA Gomafu 与糖尿病相关疾病有关。然而,其在胰岛素抵抗(IR)中的作用尚不清楚。我们的目的是探讨 Gomafu 在肝 IR 和葡萄糖耐量异常中的作用。测定 ob/ob 小鼠和高脂肪饮食(HFD)小鼠肝脏中的 Gomafu 表达。通过染色质免疫沉淀和实时定量 PCR 测定测定 NF-κB 对 Gomafu 启动子的结合活性。肥胖小鼠肝脏中观察到 Gomafu 表达增加。此外,还观察到 ob/ob 小鼠肝细胞中 NF-κB 结合在 Gomafu 启动子上。进一步的研究表明,NF-κB p65 的敲低减轻了体内和体外肝 Gomafu 表达的增加。肝 Gomafu 的敲低抑制肥胖小鼠的肝葡萄糖生成(HGP)并改善胰岛素敏感性,而肝 Gomafu 的过表达导致瘦小鼠的随机和空腹血糖水平升高。此外,我们证明 Gomafu 作为 miR-139 的海绵,并导致其靶基因 Foxo1 的去抑制,Foxo1 在肝细胞中的糖异生和 HGP 中起重要作用。最后,沉默 Foxo1 表达消除了 Gomafu 过表达对肝细胞中糖异生和葡萄糖生成的影响。总之,我们的数据表明,Gomafu 表达的增加导致肥胖小鼠的肝 IR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/d8a48e68eef6/41419_2018_321_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/69566e07b28b/41419_2018_321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/37d9f940bf8c/41419_2018_321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/cbd2742c9dd1/41419_2018_321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/6cff7c3850c6/41419_2018_321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/4cf827d67d93/41419_2018_321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/91deea7b18bf/41419_2018_321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/d8a48e68eef6/41419_2018_321_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/69566e07b28b/41419_2018_321_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/37d9f940bf8c/41419_2018_321_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/cbd2742c9dd1/41419_2018_321_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/6cff7c3850c6/41419_2018_321_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/4cf827d67d93/41419_2018_321_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/91deea7b18bf/41419_2018_321_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f0/5833404/d8a48e68eef6/41419_2018_321_Fig7_HTML.jpg

相似文献

1
Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.长链非编码 RNA Gomafu 通过海绵吸附 miR-139-5p 上调 Foxo1 表达促进肝脏胰岛素抵抗。
Cell Death Dis. 2018 Feb 19;9(3):289. doi: 10.1038/s41419-018-0321-7.
2
A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.肝脏中微小RNA-9表达的降低通过靶向肥胖小鼠中的FOXO1损害糖异生作用。
Diabetologia. 2016 Jul;59(7):1524-1532. doi: 10.1007/s00125-016-3932-5. Epub 2016 Mar 22.
3
lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.长链非编码 RNA MEG3 通过作为 miR-214 的竞争性内源性 RNA 来调节 ATF4 表达,促进肝胰岛素抵抗。
Int J Mol Med. 2019 Jan;43(1):345-357. doi: 10.3892/ijmm.2018.3975. Epub 2018 Nov 5.
4
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.微小RNA-21通过靶向叉头框蛋白O1调控肝脏葡萄糖代谢。
Gene. 2017 Sep 5;627:194-201. doi: 10.1016/j.gene.2017.06.024. Epub 2017 Jun 13.
5
Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.长链非编码 RNA Mirt2 通过海绵吸附 miR-34a-5p 上调 USP10 表达来抑制肝脂肪变性。
Gene. 2019 Jun 5;700:139-148. doi: 10.1016/j.gene.2019.02.096. Epub 2019 Mar 18.
6
Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.lncRNA MEG3的上调通过增加FoxO1表达促进肝脏胰岛素抵抗。
Biochem Biophys Res Commun. 2016 Jan 8;469(2):319-25. doi: 10.1016/j.bbrc.2015.11.048. Epub 2015 Nov 19.
7
Prostaglandin F Facilitates Hepatic Glucose Production Through CaMKIIγ/p38/FOXO1 Signaling Pathway in Fasting and Obesity.前列腺素 F 通过 CaMKIIγ/p38/FOXO1 信号通路促进禁食和肥胖时的肝糖生成。
Diabetes. 2018 Sep;67(9):1748-1760. doi: 10.2337/db17-1521. Epub 2018 May 17.
8
Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.肝 p38α MAPK 通过在小鼠胰高血糖素信号传导过程中 FOXO1 的 S273 位磷酸化来控制糖异生。
Diabetologia. 2023 Jul;66(7):1322-1339. doi: 10.1007/s00125-023-05916-5. Epub 2023 May 19.
9
Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.肥胖症中 MicroRNA-592 的下调导致高血糖和胰岛素抵抗。
EBioMedicine. 2019 Apr;42:494-503. doi: 10.1016/j.ebiom.2019.03.041. Epub 2019 Apr 1.
10
Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.环状 RNA HIPK3 通过海绵吸附 miR-192-5p 和上调转录因子叉头框 O1 促进高血糖和胰岛素稳态。
Endocr J. 2020 Apr 28;67(4):397-408. doi: 10.1507/endocrj.EJ19-0271. Epub 2019 Dec 24.

引用本文的文献

1
Stress-Related LncRNAs and Their Roles in Diabetes and Diabetic Complications.应激相关长链非编码RNA及其在糖尿病和糖尿病并发症中的作用
Int J Mol Sci. 2025 Feb 28;26(5):2194. doi: 10.3390/ijms26052194.
2
Integrative Analyses of Genes of Pediatric Non-alcoholic Fatty Liver Disease Associated with Energy Metabolism.小儿非酒精性脂肪性肝病相关能量代谢基因的综合分析
Dig Dis Sci. 2024 Dec;69(12):4373-4391. doi: 10.1007/s10620-024-08702-4. Epub 2024 Nov 4.
3
Decoding the connection between lncRNA and obesity: Perspective from humans and .

本文引用的文献

1
Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer.长链非编码 RNA MALAT1 通过 miR-23b-3p 的海绵作用调控胃癌自噬相关化疗耐药性。
Mol Cancer. 2017 Nov 21;16(1):174. doi: 10.1186/s12943-017-0743-3.
2
lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy.长链非编码 RNA MIAT 通过海绵吸附 miR-22-3p 作为竞争性内源性 RNA 上调 DAPK2 在糖尿病心肌病中的作用。
Cell Death Dis. 2017 Jul 13;8(7):e2929. doi: 10.1038/cddis.2017.321.
3
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
解读长链非编码RNA与肥胖之间的联系:来自人类的视角以及…… (原文此处不完整)
Heliyon. 2024 Jul 28;10(15):e35327. doi: 10.1016/j.heliyon.2024.e35327. eCollection 2024 Aug 15.
4
The Pathogenesis of Diabetes.糖尿病发病机制。
Int J Mol Sci. 2023 Apr 10;24(8):6978. doi: 10.3390/ijms24086978.
5
Recent advances of long non-coding RNAs in control of hepatic gluconeogenesis.长链非编码 RNA 在调控肝糖异生中的最新进展。
Front Endocrinol (Lausanne). 2023 Mar 31;14:1167592. doi: 10.3389/fendo.2023.1167592. eCollection 2023.
6
The role of long non-coding RNAs in carbohydrate and fat metabolism in the liver.长链非编码RNA在肝脏碳水化合物和脂肪代谢中的作用。
Noncoding RNA Res. 2023 Mar 14;8(3):294-301. doi: 10.1016/j.ncrna.2023.03.003. eCollection 2023 Sep.
7
lncRNA‑miRNA‑mRNA network in female offspring born from obese dams.肥胖母鼠所生雌性后代中的长链非编码RNA-微小RNA-信使核糖核酸网络
Exp Ther Med. 2023 Feb 13;25(3):140. doi: 10.3892/etm.2023.11839. eCollection 2023 Mar.
8
The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease.长链非编码RNA LINC01260在非酒精性脂肪性肝病中的作用及可能机制
Nutr Metab (Lond). 2022 Jan 12;19(1):3. doi: 10.1186/s12986-021-00634-4.
9
MicroRNA-139-5p Alleviates High Glucose-Triggered Human Retinal Pigment Epithelial Cell Injury by Targeting LIM-Only Factor 4.miR-139-5p 通过靶向 LIM 仅含 4 蛋白减轻高糖诱导的人视网膜色素上皮细胞损伤
Mediators Inflamm. 2021 Oct 23;2021:1629783. doi: 10.1155/2021/1629783. eCollection 2021.
10
LncRNA MIAT Services as a Noninvasive Biomarker for Diagnosis and Correlated with Immune Infiltrates in Breast Cancer.长链非编码RNA MIAT作为乳腺癌诊断的无创生物标志物并与免疫浸润相关
Int J Womens Health. 2021 Oct 22;13:991-1004. doi: 10.2147/IJWH.S312714. eCollection 2021.
微小RNA-21通过靶向叉头框蛋白O1调控肝脏葡萄糖代谢。
Gene. 2017 Sep 5;627:194-201. doi: 10.1016/j.gene.2017.06.024. Epub 2017 Jun 13.
4
Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing and regulating cell apoptosis.长链非编码RNA MIAT通过吸收和调节细胞凋亡,在糖尿病视网膜病变中作为一种生物标志物发挥作用。
Biosci Rep. 2017 Apr 28;37(2). doi: 10.1042/BSR20170036. Print 2017 Apr 30.
5
Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain.长链非编码RNA-MIAT促进眼和脑的神经血管重塑。
Oncotarget. 2016 Aug 2;7(31):49688-49698. doi: 10.18632/oncotarget.10434.
6
A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.肝脏中微小RNA-9表达的降低通过靶向肥胖小鼠中的FOXO1损害糖异生作用。
Diabetologia. 2016 Jul;59(7):1524-1532. doi: 10.1007/s00125-016-3932-5. Epub 2016 Mar 22.
7
Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability.长链非编码RNA MALAT1通过增加核内固醇调节元件结合蛋白-1c(SREBP-1c)的蛋白稳定性来促进肝脂肪变性和胰岛素抵抗。
Sci Rep. 2016 Mar 3;6:22640. doi: 10.1038/srep22640.
8
Role of long non-coding RNA MIAT in proliferation, apoptosis and migration of lens epithelial cells: a clinical and in vitro study.长链非编码RNA MIAT在晶状体上皮细胞增殖、凋亡和迁移中的作用:一项临床和体外研究
J Cell Mol Med. 2016 Mar;20(3):537-48. doi: 10.1111/jcmm.12755. Epub 2016 Jan 28.
9
Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.lncRNA MEG3的上调通过增加FoxO1表达促进肝脏胰岛素抵抗。
Biochem Biophys Res Commun. 2016 Jan 8;469(2):319-25. doi: 10.1016/j.bbrc.2015.11.048. Epub 2015 Nov 19.
10
Molecular pathophysiology of hepatic glucose production.肝脏葡萄糖生成的分子病理生理学
Mol Aspects Med. 2015 Dec;46:21-33. doi: 10.1016/j.mam.2015.09.003. Epub 2015 Nov 5.